HIF1A and neoplasm: Immunoreactivity of HIF-1α significantly differed by lymphovascular invasion (p = 0.009), peri-neural invasion (p = 0.002), tumor regression score (p < 0.001), pathologic complete response (p = 0.01), and HbA1c level (p = 0.046).